Literature DB >> 15920766

Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state.

Liuquan Lucy Chang1, Deanna Shepherd, Joanna Sun, Xiaolin Charlie Tang, Michael J Pikal.   

Abstract

PURPOSE: To investigate the effect of plasticizers on the stability of protein formulations in the solid state and to apply these results to a study of mechanisms of protein stabilization by sugars in the solid sate.
METHODS: The IgG1 antibody was formulated with either sucrose or trehalose alone or a mixture of sorbitol with sucrose or trehalose. After lyophilization, the pure protein and sucrose formulations were equilibrated at different relative humidities giving residual moistures from less than 1% to 5% for sucrose systems and up to 17% for pure protein systems. All the samples were stored at 50 degrees C for up to1 month and at 40 and 25 degrees C for up to 6 months. Aggregation and chemical degradation were monitored by size exclusion chromatography (SEC) and ion exchange chromatography (IEX), respectively. The secondary structure was characterized by FTIR using second derivative analysis of Amide I region. Structural relaxation times, tau, an indication of molecular mobility in the glassy matrix, were characterized using the thermal activity monitor (TAM). The tau values of the recombinant human monoclonal antibody (rhuMab) formulation with various water contents were also measured in this study and compared with stability data taken from the literature (Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ, 2001, Pharm Res 18:1345-1353).
RESULTS: The structural relaxation time, tau, decreased sharply with increasing water content. However, the stability data suggest a minimum in degradation rate at 2%-3% water content. Addition of a small amount of sorbitol to a sucrose-based formulation resulted in greater retention of native structure, smaller relaxation time, but improved stability. However, with the trehalose-based formulations, addition of sorbitol had no effect on protein structure (FTIR), but the decrease in relaxation time and the improvement in stability were qualitatively similar to the corresponding data obtained with the sucrose-based formulation.
CONCLUSION: Glass dynamics as measured by tau could not explain the stability results. Stability correlated best with the preservation of native structure for sucrose-based formulations, but with the trehalose-based formulation, neither structural relaxation time nor extent of native structure was predictive of stability. However, it is possible that the beta-relaxations rather than the alpha-relaxation (i.e., the tau we measured) is critical to the stability. Plasticizers like glycerol may decrease tau for "alpha-motion" but increase tau for "beta-motion" and stabilize proteins (Cicerone MT, Tellington A, Trost L, Sokolov A, 2003, BioProcess Inter 1:1-9). (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920766     DOI: 10.1002/jps.20363

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

1.  The use of disaccharides in inhibiting enzymatic activity loss and secondary structure changes in freeze-dried β-galactosidase during storage.

Authors:  Ville Petteri Heljo; Kirsi Jouppila; Timo Hatanpää; Anne M Juppo
Journal:  Pharm Res       Date:  2010-10-22       Impact factor: 4.200

2.  Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses.

Authors:  Sheri L Shamblin; Bruno C Hancock; Michael J Pikal
Journal:  Pharm Res       Date:  2006-08-29       Impact factor: 4.200

3.  Effects of moisture content on the storage stability of dried lipoplex formulations.

Authors:  Jinxiang Yu; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying.

Authors:  Jihea Park; Karthik Nagapudi; Camille Vergara; Ranjini Ramachander; Jennifer S Laurence; Sampathkumar Krishnan
Journal:  Pharm Res       Date:  2012-11-27       Impact factor: 4.200

6.  An intravaginal ring for the sustained delivery of antibodies.

Authors:  Manjula Gunawardana; Marc M Baum; Thomas J Smith; John A Moss
Journal:  J Pharm Sci       Date:  2014-09-17       Impact factor: 3.534

7.  Characterization of dynamics in complex lyophilized formulations: II. Analysis of density variations in terms of glass dynamics and comparisons with global mobility, fast dynamics, and Positron Annihilation Lifetime Spectroscopy (PALS).

Authors:  Norman Chieng; Marcus T Cicerone; Qin Zhong; Ming Liu; Michael J Pikal
Journal:  Eur J Pharm Biopharm       Date:  2013-04-25       Impact factor: 5.571

8.  Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.

Authors:  Sumie Yoshioka; Tamaki Miyazaki; Yukio Aso; Tohru Kawanishi
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

9.  Nebulization of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury.

Authors:  Soraya Hengsawas Surasarang; Sawittree Sahakijpijarn; Galina Florova; Andrey A Komissarov; Christina L Nelson; Enkhbaatar Perenlei; Satoshi Fukuda; Marla R Wolfson; Thomas H Shaffer; Steven Idell; Robert O Williams
Journal:  J Drug Deliv Sci Technol       Date:  2018-04-30       Impact factor: 3.981

10.  Effects of di- and polysaccharide formulations and storage conditions on survival of freeze-dried Sphingobium sp.

Authors:  Karin Onneby; Leticia Pizzul; Joakim Bjerketorp; Denny Mahlin; Sebastian Håkansson; Per Wessman
Journal:  World J Microbiol Biotechnol       Date:  2013-03-10       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.